Intranasal and intraperitoneal administration of C19 peptide to allergic rhinitis mice relieved symptoms and decreased serum IgE concentrations, with better efficacy of intranasal than intraperitoneal delivery (32). This evidence concerns the gene IGHE and allergic rhinitis.